Table 2.
Demographic and Clinical Characteristics of the Eyes with Retinal Neovascularization
| Parameters | (n = 20) |
|---|---|
| Age, yrs (SD) [95% CI] | 53.5 (12.3) [47.7–59.2] |
| Sex, n (male/female) | 11/9 |
| Most recent HbA1c, % (SD) [95% CI] | 8.0 (2.3) [6.8–9.1] |
| Duration of DM, yrs (SD) [95% CI] | 21.7 (12.4) [15.9–27.5] |
| Type 1 DM, n (%) | 10 (50) |
| Follow-up duration, mos (SD) [95% CI] | 15.5 (10.8) [10.4–20.6] |
| OCTA scans, n (SD) [95% CI] | 3.4 (1.2) [2.8–3.9] |
| DR stage | |
| Mild NPDR, eyes (%) | 0 (0) |
| Moderate NPDR, eyes (%) | 1 (5.0) |
| Severe NPDR, eyes (%) | 6 (30.0) |
| PDR, eyes (%) | 13 (65.0) |
| Treatment naive, eyes (%) | 11 (55) |
| Previous treatment | |
| Panretinal photocoagulation, eyes | 4 |
| Intravitreal VEGF injection, eyes | 5 |
CI = confidence interval; DM = diabetes mellitus; DR = diabetic retinopathy; HbA1c = hemoglobin A1c; NPDR = nonproliferative diabetic retinopathy; PDR = proliferative diabetic retinopathy; SD = standard deviation.